Salicylates, a class of NSAIDs, stop vestibular schwannomas growth

(Massachusetts Eye and Ear Infirmary) Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news